Cost effectiveness of saxagliptin and metformin versus sulfonylurea and metformin in the treatment of type 2 diabetes mellitus in Germany: a Cardiff diabetes model analysis (Q45402744)

From Wikidata
Jump to navigation Jump to search
scientific article published in March 2012
edit
Language Label Description Also known as
English
Cost effectiveness of saxagliptin and metformin versus sulfonylurea and metformin in the treatment of type 2 diabetes mellitus in Germany: a Cardiff diabetes model analysis
scientific article published in March 2012

    Statements

    Cost effectiveness of saxagliptin and metformin versus sulfonylurea and metformin in the treatment of type 2 diabetes mellitus in Germany: a Cardiff diabetes model analysis (English)
    Wilma Erhardt
    Klas Bergenheim
    Isabelle Duprat-Lomon
    Phil McEwan
    1 March 2012
    189-202

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit